Want to see GB:AZN full AI Analyst Report?
AstraZeneca (AZN) Ratios
AstraZeneca Ratios
GB:AZN's free cash flow for Q3 2026 was $4.08B. For the 2026 fiscal year, GB:AZN's free cash flow was decreased by $-681.29M and operating cash flow was $4.76B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.94 | 0.93 | 0.81 | 0.86 | 1.16 |
| Quick Ratio | 0.72 | 0.74 | 0.64 | 0.68 | 0.76 |
| Cash Ratio | 0.19 | 0.20 | 0.19 | 0.23 | 0.28 |
| Solvency Ratio | 0.24 | 0.19 | 0.18 | 0.14 | 0.06 |
| Operating Cash Flow Ratio | 0.48 | 0.43 | 0.34 | 0.37 | 0.26 |
| Short-Term Operating Cash Flow Coverage | 4.70 | 5.50 | 2.11 | 1.88 | 3.81 |
| Net Current Asset Value | $ -36.63B | $ -37.36B | $ -37.11B | $ -36.83B | $ -39.94B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.26 | 0.29 | 0.28 | 0.30 | 0.29 |
| Debt-to-Equity Ratio | 0.61 | 0.74 | 0.73 | 0.79 | 0.78 |
| Debt-to-Capital Ratio | 0.38 | 0.42 | 0.42 | 0.44 | 0.44 |
| Long-Term Debt-to-Capital Ratio | 0.34 | 0.39 | 0.36 | 0.38 | 0.42 |
| Financial Leverage Ratio | 2.34 | 2.55 | 2.58 | 2.61 | 2.68 |
| Debt Service Coverage Ratio | 3.68 | 3.76 | 2.02 | 1.54 | 2.13 |
| Interest Coverage Ratio | 8.11 | 9.19 | 8.31 | 5.69 | 3.70 |
| Debt to Market Cap | 0.10 | 0.14 | 0.13 | 0.13 | 0.18 |
| Interest Debt Per Share | 20.20 | 20.31 | 18.92 | 19.40 | 22.18 |
| Net Debt to EBITDA | 1.21 | 1.66 | 1.71 | 2.66 | 5.32 |
| Profitability Margins | |||||
| Gross Profit Margin | 81.90% | 74.98% | 73.95% | 63.36% | 60.90% |
| EBIT Margin | 24.00% | 18.70% | 17.56% | 7.65% | 1.51% |
| EBITDA Margin | 33.76% | 28.06% | 28.33% | 19.50% | 12.36% |
| Operating Profit Margin | 23.40% | 23.65% | 20.54% | 11.41% | 7.57% |
| Pretax Profit Margin | 21.11% | 16.07% | 15.06% | 5.64% | -0.70% |
| Net Profit Margin | 17.41% | 13.01% | 13.00% | 7.41% | 0.30% |
| Continuous Operations Profit Margin | 17.42% | 13.02% | 13.01% | 7.42% | 0.30% |
| Net Income Per EBT | 82.45% | 80.95% | 86.32% | 131.47% | -42.26% |
| EBT Per EBIT | 90.24% | 67.96% | 73.31% | 49.43% | -9.25% |
| Return on Assets (ROA) | 8.96% | 6.62% | 5.99% | 3.40% | 0.10% |
| Return on Equity (ROE) | 21.01% | 16.89% | 15.47% | 8.86% | 0.28% |
| Return on Capital Employed (ROCE) | 16.47% | 16.44% | 13.56% | 7.19% | 3.39% |
| Return on Invested Capital (ROIC) | 13.04% | 12.90% | 10.94% | 6.67% | -1.44% |
| Return on Tangible Assets | 18.60% | 15.03% | 14.09% | 8.78% | 0.26% |
| Earnings Yield | 3.56% | 3.39% | 2.87% | 1.56% | 0.07% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.59 | 4.05 | 3.94 | 4.81 | 4.24 |
| Payables Turnover | 0.42 | 3.64 | 3.71 | 6.36 | 5.14 |
| Inventory Turnover | 1.62 | 2.51 | 2.26 | 3.45 | 1.62 |
| Fixed Asset Turnover | 4.00 | 4.55 | 4.44 | 4.68 | 3.65 |
| Asset Turnover | 0.51 | 0.51 | 0.46 | 0.46 | 0.35 |
| Working Capital Turnover Ratio | -29.67 | -13.64 | -9.91 | -563.30 | 27.65 |
| Cash Conversion Cycle | -541.16 | 135.45 | 156.22 | 124.19 | 240.18 |
| Days of Sales Outstanding | 101.54 | 90.18 | 92.72 | 75.82 | 86.16 |
| Days of Inventory Outstanding | 225.08 | 145.57 | 161.76 | 105.79 | 225.07 |
| Days of Payables Outstanding | 867.79 | 100.31 | 98.26 | 57.41 | 71.05 |
| Operating Cycle | 326.62 | 235.75 | 254.49 | 181.60 | 311.23 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 9.40 | 7.65 | 6.62 | 6.34 | 4.21 |
| Free Cash Flow Per Share | 5.59 | 4.69 | 4.20 | 4.68 | 2.65 |
| Dividend Paid and CapEx Coverage Ratio | 1.34 | 1.29 | 1.25 | 1.41 | 0.98 |
| Capital Expenditure Coverage Ratio | 2.47 | 2.59 | 2.74 | 3.81 | 2.71 |
| Operating Cash Flow Coverage Ratio | 0.49 | 0.39 | 0.36 | 0.34 | 0.19 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.22 | 0.22 | 0.22 | 0.16 |
| Free Cash Flow Yield | 3.01% | 3.58% | 3.12% | 3.45% | 2.26% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 28.11 | 29.47 | 34.81 | 63.97 | 1515.87 |
| Price-to-Sales (P/S) Ratio | 4.90 | 3.83 | 4.52 | 4.74 | 4.49 |
| Price-to-Book (P/B) Ratio | 5.91 | 4.98 | 5.38 | 5.67 | 4.24 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 33.17 | 27.90 | 32.10 | 29.00 | 44.25 |
| Price-to-Operating Cash Flow Ratio | 19.73 | 17.11 | 20.37 | 21.40 | 27.93 |
| Price-to-Earnings Growth (PEG) Ratio | 0.58 | 2.17 | 0.41 | 0.02 | -15.63 |
| Enterprise Value Multiple | 15.71 | 15.32 | 17.69 | 26.98 | 41.63 |
| Enterprise Value | 311.51B | 227.63B | 233.39B | 232.85B | 190.91B |
| EV to EBITDA | 15.71 | 15.32 | 17.69 | 26.98 | 41.63 |
| EV to Sales | 5.30 | 4.30 | 5.01 | 5.26 | 5.14 |
| EV to Free Cash Flow | 35.93 | 31.29 | 35.54 | 32.18 | 50.73 |
| EV to Operating Cash Flow | 21.37 | 19.19 | 22.56 | 23.74 | 32.01 |
| Tangible Book Value Per Share | -6.69 | -11.18 | -12.04 | -14.26 | -16.29 |
| Shareholders’ Equity Per Share | 31.40 | 26.31 | 25.06 | 23.93 | 27.69 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.17 | 0.19 | 0.14 | -0.32 | 1.43 |
| Revenue Per Share | 37.90 | 34.16 | 29.82 | 28.59 | 26.17 |
| Net Income Per Share | 6.60 | 4.44 | 3.88 | 2.12 | 0.08 |
| Tax Burden | 0.82 | 0.81 | 0.86 | 1.31 | -0.42 |
| Interest Burden | 0.88 | 0.86 | 0.86 | 0.74 | -0.46 |
| Research & Development to Revenue | 0.24 | 0.23 | 0.23 | 0.22 | 0.23 |
| SG&A to Revenue | 0.35 | 0.29 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 |
| Income Quality | 1.18 | 1.36 | 1.50 | 3.92 | -22.50 |
Currency in USD